Drugs / Influenza antigen
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03437304 | Feb → Jun 2018 | influenza | Eurocine Vaccines AB | Completed | No outcome recorded |
| Phase 1/2 | NCT02998996 | Sep 2016 → Jun 2017 | influenza | Eurocine Vaccines AB | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza antigen | “Influenza antigen,” NCT02998996 ↗ |
| Modality | Vaccine | “Quadrivalent influenza vaccine” NCT03437304 ↗ |
| Route | Intranasal | “intranasal administration” NCT02998996 ↗ |